Filing Signals

Source: SEC EDGAR Compiled 2026-11-14 10:32 UTC 23 automated checks passing

← All events

Viking Therapeutics, Inc.

CIK 1607678 VKTX·Pharmaceutical Preparations · All EDGAR filings ↗

Accounting standard newly cited Filing comparison

Viking Therapeutics, Inc. cited accounting standard ASU 2014-09 for the first time in this filing series

The Company adopted FASB ASU No. 2014-09, Revenue from Contracts with Customers and all related amendments (“ASC 606” or “the revenue standard”).
Evidence
Adopted
2014-09
Contexts
The Company adopted FASB ASU No. 2014-09, Revenue from Contracts with Customers and all related amendments (“ASC 606” or “the revenue standard”).
New standards
2014-09, 2025-11
Prior filed
2026-07-29
Prior form
10-Q
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.